Daniel Lightwood, PhDDirector, Antibody Discovery at UCB CelltechSpeaker
Profile
After receiving a first class BSc Hons degree at Reading University, UK (1996), I undertook a PhD at the University of Cambridge, Biochemistry Department in the area of protein engineering (graduated 1999). I then joined Celltech (acquired by UCB in 2004) in 1999. During my 15 years at UCB Celltech, I have played a key role in developing UCB’s antibody discovery platform and have been responsible for successfully applying the technology across a number of UCB therapeutic antibody programs. I have recently managed the implementation and launch of a new automated antibody discovery platform. This allows for unparalleled immune sampling and is providing UCB with efficiency savings and results in the generation of very high quality monoclonal antibodies. I currently hold the position of Director, Antibody Discovery at UCB Celltech managing the Core Antibody Discovery team.